COVID-19 in 2026: Symptoms, Whether You Need Paxlovid, and When It's an Emergency

Written by Dr. Casey Dean, DO, Board-Certified Family Medicine Physician | Medically reviewed by Dr. Kathryn Kline, MD | Trinity Family Medicine

Last medically reviewed: September 2026

About the author: Dr. Casey Dean is a board-certified family medicine physician (ABFM) who treats respiratory infections, including COVID-19, and manages the chronic conditions that raise COVID risk for patients across Texas via primary care and telehealth.

COVID-19 has not gone away — it has simply become part of the ordinary respiratory season, alongside flu and RSV. It still sends people to the hospital, and it still causes lingering illness: the CDC's Household Pulse Survey has found that roughly 1 in 20 U.S. adults (about 5%) report currently having long COVID. Most 2026 infections, though, look far milder than the early waves. Maybe you have a scratchy throat and a cough this fall. You're wondering whether it's COVID, whether you need Paxlovid, and when a home illness becomes an emergency. This physician-written guide walks through what actually matters in 2026.

Quick Summary: Key Facts at a Glance

Emergency warning: Call 911 right away for trouble breathing, persistent chest pain or pressure, new confusion, an inability to wake or stay awake, or bluish lips or face. These are signs of severe COVID-19, which typically develops about a week after the first symptoms.

What Are the Symptoms of COVID-19 in 2026?

The most common COVID-19 symptoms in 2026 are sore throat, a dry or tickly cough, nasal congestion or runny nose, fatigue, headache, muscle aches, and a mild fever or chills. This looks very different from 2020. Newer Omicron-lineage variants — the descendants of the Omicron strain that now dominate — tend to infect the upper airway (the nose and throat) rather than deep lung tissue, so many infections feel like a bad cold. The classic loss of taste or smell that once defined COVID is now reported in fewer than 10% of confirmed cases.

Because the symptoms overlap so heavily with other illnesses, symptoms alone cannot tell you what you have. A sore throat and congestion in the fall could be COVID-19, influenza, RSV, a common cold, strep throat, or even Texas seasonal allergies. The only reliable way to confirm COVID specifically is a test — symptoms are a clue, not a diagnosis.

How Can You Tell COVID From a Cold, the Flu, or Allergies?

You often can't tell them apart by symptoms alone, which is exactly why testing matters when the answer would change your care. A few patterns help: the flu tends to hit suddenly with high fever and body aches; a cold builds gradually and rarely causes a high fever; allergies cause itchy eyes and sneezing without fever and last for weeks. COVID can mimic any of these. If you are higher-risk, or if you need to protect someone vulnerable at home, testing is worthwhile because COVID and flu each have specific antiviral treatments that a cold does not.

Do You Need to Test for COVID-19?

Testing is most useful when a positive result would actually change what you do. A home rapid antigen test — the common at-home nasal swab that gives a result in about 15 minutes — is a reasonable first step, especially if you are at higher risk for severe disease, live or work with vulnerable people, or want to know whether you qualify for an antiviral. If your first home test is negative but symptoms continue, the FDA advises repeat testing in 48 hours, because antigen tests can miss early infection. A PCR (molecular) test is more sensitive than a home antigen test and can confirm the result when the answer would change your care. A telehealth clinician can help interpret your test in the context of your symptoms and exposure.

What this means in plain English: If you're young, healthy, and just want to rest at home, a test may not change anything — but if you're higher-risk, testing is the gateway to treatment that works best when started early.

How Is COVID-19 Treated in 2026?

For most healthy adults, COVID-19 is treated with supportive care: rest, fluids, and over-the-counter medicines like acetaminophen or ibuprofen for fever and aches. For people at higher risk of severe illness, the main treatment is an oral antiviral started early. The single most important factor is timing — the oral antivirals Paxlovid and molnupiravir must be started within 5 days of symptom onset (remdesivir, an intravenous option, can begin within 7 days but requires an infusion visit, so it isn't a telehealth option).

Paxlovid (nirmatrelvir/ritonavir) is the preferred oral antiviral for eligible high-risk outpatients — a medicine that stops the virus from multiplying. According to the FDA, it is indicated for adults with mild-to-moderate COVID-19 who are at high risk of progressing to severe disease. In the EPIC-HR trial published in the New England Journal of Medicine (2022), Paxlovid started within 5 days cut the chance of COVID-related hospitalization or death by about 86% in unvaccinated high-risk adults. In that trial, 0.9% of treated patients were hospitalized or died, compared with 6.5% of those who got a placebo (an inactive pill). Molnupiravir (Lagevrio) is an alternative antiviral for certain adults when Paxlovid isn't appropriate; it is also started within 5 days.

A note on side effects and interactions: Paxlovid commonly causes an altered or metallic taste and diarrhea. It also interacts with many common medications, including certain statins, blood thinners, and heart-rhythm drugs. Because of this, a clinician must review your full medication list before prescribing it. Molnupiravir's most common side effects are diarrhea, nausea, and dizziness. Some people experience a "rebound," where symptoms or a positive test return a few days after finishing Paxlovid. Research analyzing the EPIC-HR trial found this rebound was not linked to hospitalization or death, and it can also happen without any treatment.

Which COVID Patients Actually Need an Antiviral?

Antivirals are aimed at people most likely to get seriously ill, not everyone with a positive test. Risk of severe COVID-19 rises sharply with age — especially after 65 — and with conditions such as diabetes, obesity, heart, lung, kidney, or liver disease, pregnancy, or a weakened immune system. The table below outlines how clinicians commonly think about it — a clinician makes the final call based on your history, medications, and how far into the illness you are.

What this means in plain English: If you're young and healthy, you probably just need rest — but if you're older or have a chronic condition, don't wait to be seen, because the treatment window is only five days.

Do You Still Need the COVID Vaccine in 2026?

An updated vaccine is available for the 2026-2027 season, and the decision to get one is now framed as a conversation with your clinician. The FDA has approved updated 2026-2027 formulations of Comirnaty (Pfizer/BioNTech), Spikevax and mNEXSPIKE (Moderna), and Nuvaxovid (Novavax), all reformulated to target the XFG variant, a descendant of the JN.1 lineage. In 2025-2026, the CDC's Advisory Committee on Immunization Practices moved to "shared clinical decision-making" for people ages 6 months and older — meaning you and your clinician weigh your personal risk factors together rather than following a single blanket rule.

What this means in plain English: The benefit of vaccination is generally greatest for those at higher risk of severe COVID — older adults, pregnant patients, and people with chronic conditions or weakened immune systems. A short telehealth or in-person visit is a good place to decide whether it's right for you.

Can You Treat COVID-19 During Pregnancy?

Yes, but treatment is individualized, because pregnancy itself raises the risk of severe COVID-19. Pregnant patients are considered a higher-risk group, so early evaluation matters. Paxlovid may be considered in pregnancy after a clinician weighs the benefits and risks, while molnupiravir is avoided in pregnancy. The American College of Obstetricians and Gynecologists (ACOG) recommends COVID-19 vaccination in pregnancy. If you are pregnant and test positive, contact a clinician promptly rather than waiting the illness out, and confirm any medication with your obstetric provider.

How Long Is COVID-19 Contagious, and When Can You Go Back to Normal?

Under the CDC's unified respiratory virus guidance, you can return to normal activities once your symptoms have been improving overall and you have been fever-free for at least 24 hours without using fever-reducing medicine. For the next 5 days, the CDC recommends added precautions: wearing a well-fitting mask, improving ventilation, distancing where you can, cleaning hands often, and testing before gathering with others.

Dr. Dean's clinical perspective: The question worth asking yourself is not "have I hit a magic number of days," but "am I actually getting better and truly fever-free without Tylenol?" Being fever-free for 24 hours lowers the risk of spreading the virus — it does not guarantee you are no longer contagious, which is why those extra few days of precautions around vulnerable people still matter.

When Should You See a Doctor for COVID-19?

See a clinician promptly if you are in a higher-risk group and test positive, if your symptoms are worsening rather than improving, or if you are unsure whether you qualify for an antiviral. A clinician can confirm your risk level, review your medications for interactions, rule out other causes of your symptoms, and prescribe an antiviral when it's appropriate — all of which are most valuable inside the 5-day treatment window.

This is a good fit for telehealth. A Trinity Family Medicine physician can assess whether your symptoms and test result are consistent with COVID-19, discuss whether an antiviral makes sense for you, and send a prescription to your pharmacy when treatment is appropriate. We see patients across Texas, with visits starting at $49.99. You can book at trinitymedtx.com or call 817-932-4022. For any emergency red-flag symptom, though, telehealth is not the answer — call 911 or go to the nearest emergency room.

For related respiratory questions, see our guides on flu symptoms and when Tamiflu is worth it, when pneumonia needs antibiotics, and whether a sinus infection needs antibiotics.

Frequently Asked Questions About COVID-19 in 2026

The Bottom Line

In 2026, COVID-19 is usually a mild upper-respiratory illness that resolves with rest and fluids, but it remains genuinely dangerous for older adults, pregnant patients, and people with chronic conditions. For them, an antiviral started within 5 days can substantially reduce the risk of hospitalization. Know your own risk level, test when a result would change your care, and don't wait out symptoms if you're higher-risk. The most important number in COVID treatment is 5 — the days you have to start an oral antiviral like Paxlovid, which is why higher-risk patients should reach a clinician early rather than waiting to see if things get worse.

References